|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.17/-0.16
|
Enterprise Value
1.02B
|
Balance Sheet |
Book Value Per Share
0.13
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
4.61M
|
Operating Revenue Per Share
0.02
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/05 23:33 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. |